Crispr Therapeutics AG Logo

Crispr Therapeutics AG (CRSP): Eigentümerstruktur

Takani Score ?
21.1

Preis (12.10.2026)52W Hoch52W Tief
51,55 US Dollar75,06 US Dollar44,12 US Dollar
Analysten KonsensBuy Outperform Hold Underperform Sell
87,5 US Dollar8 5 9 0 0
Externe Analystenschätzungen (Quelle: EODHD). Keine Anlageberatung, keine Anlageempfehlung von Takani.
#SharesShort [%] Short Ratio
96.692.65322,12 11,76

Eigentümerstruktur

Analyse der Aktionärsstruktur und institutionellen Investoren

Unternehmensdaten

Grundlegende Informationen

Grunddaten

Name Crispr Therapeutics AG
Mitarbeiter 393
Handelsplatz NASDAQ
Ticker Symbol CRSP
IPO Datum 2016-10-19
Adresse Baarerstrasse 14, Zug, Switzerland, 6300

Unternehmensführung

RangNamePosition
1Dr. Samarth Kulkarni Ph.D.CEO & Chairman
2Dr. Raju Yashaswi Prasad Ph.D.Chief Financial Officer
3Mr. James R. Kasinger J.D.General Counsel & Secretary
4Dr. Naimish Patel C.M., M.D.Chief Medical Officer
5Mr. Shaun Foy CFACo-Founder
6Dr. Emmanuelle Marie Charpentier Ph.D.Co-Founder & Scientific Advisory Board Member
7Dr. Craig C. Mello Ph.D.Scientific Founder & Advisory Board Member
8Dr. Chad A. Cowan Ph.D.Scientific Founder
9Dr. Matthew Porteus M.D., Ph.D.Scientific Founder & Advisory Board Member
10Dr. Daniel G. Anderson Ph.D.Scientific Founder & Advisory Board Member

Aktionärsverteilung

Aufteilung der Investoren

Größte Investoren

RangInhaberAnteileWert
1ARK Investment Management LLC9,78%0,51 Mrd. USD
2BlackRock Inc8,63%0,45 Mrd. USD
3Orbis Allan Gray Ltd5,64%0,29 Mrd. USD
4Capital World Investors4,91%0,25 Mrd. USD
5State Street Corp4,47%0,23 Mrd. USD
6GSK PLC3,33%0,17 Mrd. USD
7Geode Capital Management, LLC2,60%0,13 Mrd. USD
8T. Rowe Price Investment Management,Inc.2,12%0,11 Mrd. USD
9SR ONE CAPITAL MANAGEMENT, LP2,11%0,11 Mrd. USD
10Two Sigma Investments LLC2,06%0,11 Mrd. USD
11FMR Inc1,97%0,10 Mrd. USD
12Sumitomo Mitsui Trust Group Inc1,78%0,09 Mrd. USD
13Amova Asset Management Americas, Inc1,78%0,09 Mrd. USD
14EcoR1 Capital, LLC1,44%0,07 Mrd. USD
15UBS Group AG1,36%0,07 Mrd. USD
16Capital Research & Mgmt Co - Division 31,31%0,07 Mrd. USD
17Vanguard Capital Management, LLC1,22%0,06 Mrd. USD
18Bank of America Corp1,19%0,06 Mrd. USD
19NEA Management Company, LLC1,09%0,06 Mrd. USD
20Charles Schwab Investment Management Inc1,09%0,06 Mrd. USD